[EN] BRIDGED LIPOGLYCOPEPTIDES THAT POTENTIATE THE ACTIVITY OF BETA-LACTAM ANTIBACTERIALS<br/>[FR] LIPOGLYCOPEPTIDES PONTÉS QUI POTENTIALISENT L'ACTIVITÉ DES ANTIBACTÉRIENS BÊTA-LACTAME
申请人:MERCK SHARP & DOHME
公开号:WO2011112441A1
公开(公告)日:2011-09-15
The present invention provides novel lipoglycopeptide compounds which are Type 1 signal peptidase inhibitors (SpsB). Compounds of the present invention are useful for the treatment of various bacterial related infectious diseases, particularly when used as a potentiator of a β-lactam antibiotic such as imipenem and ertapenem. Accordingly, the present invention provides a method for the treatment of bacterial related infections using the compounds described herein, either alone or in combination with a β-lactam antibiotic.